FOXP3 and type 1 diabetes mellitus: Our findings showed that EPE treatment in both S-NOD and Cyp-NOD mice lowered blood glucose levels and increased the number of Foxp3 subsets of CD4+ T cells and reduced blood cytokine levels of TGF-β1, suggesting that EPE has potential protective effects in T1D.